Cargando…
Potentials of saponins-based adjuvants for nasal vaccines
Respiratory infections are a major public health concern caused by pathogens that colonize and invade the respiratory mucosal surface. Nasal vaccines have the advantage of providing protection at the primary site of pathogen infection, as they induce higher levels of mucosal secretory IgA antibodies...
Autores principales: | Chen, Kai, Wang, Ning, Zhang, Xiaomin, Wang, Meng, Liu, Yanyu, Shi, Yun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067588/ https://www.ncbi.nlm.nih.gov/pubmed/37020548 http://dx.doi.org/10.3389/fimmu.2023.1153042 |
Ejemplares similares
-
Potentiating pneumococcal glycoconjugate vaccine PCV13 with saponin adjuvant VSA-1
por: Kim, Hyunjung, et al.
Publicado: (2022) -
Novel Oxime-Derivatized Synthetic Triterpene Glycosides as Potent Saponin Vaccine Adjuvants
por: Fuentes, Roberto, et al.
Publicado: (2022) -
Natural and Synthetic Saponins as Vaccine Adjuvants
por: Wang, Pengfei
Publicado: (2021) -
cGAMP/Saponin Adjuvant Combination Improves Protective Response to Influenza Vaccination by Microneedle Patch in an Aged Mouse Model
por: Vassilieva, Elena V., et al.
Publicado: (2021) -
Combination of STING Pathway Agonist With Saponin Is an Effective Adjuvant in Immunosenescent Mice
por: Vassilieva, Elena V., et al.
Publicado: (2019)